Shanghai Bio-heart Biological Technology Co., Ltd. (SEHK: 2185)
Health Care · Health Care Equipment & Supplies · CN
HK$2.10
-5.83% today · -74.9% 1Y
Shanghai Bio-heart Biological Technology Co., Ltd. (SEHK: 2185) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $65.20M and employs 65 people.
Over the last twelve months the share price has lost 74.9%, trading between 1.82 and 9.26.
Tweenvest scores Shanghai Bio-heart Biological Technology Co., Ltd. across four factors: quality 38/100, value 62/100. Its strongest factor is value.
2185 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $65.20M
- Revenue (TTM)
- $6.42M
- P/E
- —
- EPS
- -0.29
- Dividend yield
- —
- Beta (5Y)
- 0.09
- 52-week high
- HK$9.26
- 52-week low
- HK$1.82
- Avg volume (3M)
- —
- Shares outstanding
- 243.42M
- Employees
- 65
- Next earnings
- —
About Shanghai Bio-heart Biological Technology Co., Ltd.
Based in the People's Republic of China, Shanghai Bio-heart Biological Technology Co., Ltd. is a medical technology firm specializing in interventional cardiovascular devices. Its core business revolves around delivering bioresorbable scaffolds (BRS) and renal denervation (RDN) therapies to address conditions like coronary artery diseases and persistent, uncontrolled high blood pressure. The company's product pipeline features Bioheart, a BRS system designed for percutaneous coronary interventions for coronary artery disease; Iberis 2nd, a multi-electrode RDN product candidate; and a sirolimus drug-eluting balloon catheter intended for managing in-stent restenosis. Furthermore, the company has partnered with Terumo (China) Investment Co., Ltd. to conduct clinical trials for Iberis 2nd. Shanghai Bio-heart Biological Technology Co., Ltd. was established in 2014 and maintains its headquarters in Shanghai, China.
- ISIN
- CNE100004JH3
- Founded
- 2014
- Listed since
- Dec 23, 2021
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $201.88B | $116.67 | +0.03% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $131.97B | $375.01 | +0.39% |
| Stryker CorporationNYSE: SYK | $125.74B | $327.81 | -0.50% |
| Medtronic plcNYSE: MDT | $118.91B | $92.90 | -0.48% |
| EssilorLuxottica Société anonymeENXTPA: EL | $86.72B | €160.25 | -0.90% |
| Boston Scientific CorporationNYSE: BSX | $71.03B | $49.11 | +0.20% |
| Siemens Healthineers AGXTRA: SHL | $52.46B | €40.06 | -0.82% |
| HOYA CorporationTSE: 7741 | $52.35B | ¥24,895.00 | -1.37% |
Figures last refreshed Aug 18, 2026.